Introduction
Non-Hodgkin lymphoma (NHL) is a heterogeneous group of neoplasms, developing from B-cell, T-cell, and natural killer (NK)/T-cell, with various clinical and biological features. 1 There were ~355,900 new cases and 191,400 deaths from NHL worldwide in 2008. 2 The numbers continued to increase with estimated 385,700 new cases and 199,700 deaths in 2012. 3 Epidemiologic studies have examined the etiology of NHL, identifying smoking, alcohol use, infectious agents, family history of lymphoma, autoimmune disease, asthma, and radiation exposure as risk factors.
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gao et al pooled the data of eight studies from an International Lymphoma Epidemiology Consortium, 12 which only examined patients with diffuse large B-cell lymphomas (DLBCL) and follicular lymphomas (FL) in Caucasians, the most common forms of NHL. 15 In 2010, Skibola et al extended the previous study and examined the risk of TNF-308G.A in NHL and other subtypes in different ethnicities. 13 The recent study by Zhai et al further pooled the data of 18 studies and examined this association in a larger population. 14 However, odds ratio (OR) was either estimated using unconditional logistic regression models in the previous two meta-analyses 12, 13 or only examined in additive model (A vs G) in the recent one.
14 Besides, this association was merely analyzed in ethnicity subgroups in the previous metaanalyses without stratification by the source of controls. Moreover, the prognosis value of TNF-308A in patients with NHL had not been examined in the previous meta-analyses.
We, therefore, performed this meta-analysis, aiming to further evaluate the association between TNF-308G.A and the susceptibility to NHL under five genetic models and exploring the potential difference among ethnicities and sources of controls, as well as its correlation with survival outcome in patients with NHL.
Materials and methods
Publication search
The databases of PubMed, Web of Science, Elsevier, HighWire, Scopus, and Google Scholar were searched up to May 2015 using the following terms: "TNF-308G.A polymorphism, rs1800629, or tumor necrosis factor-alpha" and "non-Hodgkin lymphomas, NHL, or lymphomas." Additional studies in the reference list of key articles and relevant reviews were also identified manually to further refine our research results. All the articles were retrieved independently by two researchers (S Gao and G Zhu).
selection criteria
The articles included should meet the following criteria: 1) the study should be a case-control design; 2) the study should have investigated the association of TNF-308 with the risk of NHL or prognosis; 3) data should be available to calculate OR or hazard ratio (HR); and 4) subjects included in the study should not be a human immunodeficiency virus (HIV)-negative population. In addition, the data of the same population reported in more than one study should be used only once.
Data extraction
A standard data collection form was used to extract the relevant information by two investigators (S Gao and Y Lin) independently, which included the first author, year of publication, sample size, ethnicity, source of control, and the genotype distribution of cases and controls or HRs with corresponding 95% confidence intervals (CIs). If HR was not reported in the article, Engauge Digitizer Version 4.1 was used to estimate the HR and 95% CI. The ethnicities were categorized as Caucasian or Asian, and the source of controls was categorized as population based or hospital based. Any discrepancies were discussed to reach an agreement.
statistical analysis
For susceptibility analysis, Hardy-Weinberg equilibrium (HWE) of each study was assessed by chi-square test in controls with P,0.05, which was considered a departure from HWE. OR was used to measure the strength of the association between TNF-308G.A and the risk of NHL. Pooled OR was assessed under the allelic (A vs G), dominant (AA/GA vs GG), recessive (AA vs GA/GG), homozygous (AA vs GG), and heterozygous models (GA vs GG). The heterogeneity among the studies was estimated by Q-test and I 2 value; if I 2 .50%, which was considered significant heterogeneity, a random-or fixed-effect model was used. Subgroup analysis was implemented, which was stratified by ethnicity and the source of controls. When a large amount of heterogeneity was exhibited, meta-regression analysis or sensitivity analysis was performed to explore the source of heterogeneity. Funnel plots and Egger's test were applied to estimate the potential publication bias.
For survival outcome, HR with 95% CI was used to estimate the association between TNF-308A and prognosis in patients with NHL. The heterogeneity among studies was evaluated by Q-test and I 2 value. If I 2 .50%, which was considered significant heterogeneity, a random-or fixedeffect model was employed. Sensitivity analysis was also conducted to examine the influence of single study on pooled estimate. Publication bias was evaluated by funnel plots and Egger's test.
All the analyses were implemented with Stata Version 11.0. P,0.05 was considered statistically significant, and all P-values were two sided.
Results
The titles and abstracts of 221 records from the databases and another 18 articles from the reference lists were screened for eligibility. Eventually, 17 articles met the abovementioned criteria, 9, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] where nine studies were further excluded because of the following reasons: insufficient data in six articles, 5, 6, 10, [32] [33] [34] the subjects were HIV-positive patients, 35 or studies focused on the risk of relapse (Figure 1) . 11 Among Figure 3A ). In the subgroup analysis based on the source of controls, the risk was only reduced in hospitalbased studies when GA genotype was compared with GG genotype (OR =0.838, 95% CI: 0.732-0.961, P=0.011; Figure 3B ).
TnF-308g.a polymorphism and the risk of B-cell lymphomas and its subtypes Figure 4A ). In the stratified analysis by the source of controls, a significant increased risk of BCL was found in population-based studies under the allelic model (A vs G, OR =1.2, 95% CI: 1.003-1.437, P=0.047), whereas decreased risk was found in hospital-based studies under heterozygous model (GA vs GG, OR =0.832, 95% CI: 0.751-0.967, P=0.017; Figure 4B ). 
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TnF-308 polymorphism and the risk of nhl and prognosis There was no significant association between TNF-308G.A polymorphism and the susceptibility to DLBCL, when all the data of DLBCL were pooled together. This association was only identified in Caucasians under the allelic (A vs G, OR =1.172, 95% CI: 1.035-1.325, P=0.012), dominant (AA/GA vs GG, OR =1.18, 95% CI: 1.047-1.33, P=0.007), and heterozygous models (GA vs GG, OR =1.155, 95% CI: 1.023-1.304, P=0.02; Figure 5A and Table 2 ). When stratified by the source of controls, the risk was increased in population-based studies under allelic (A vs G, OR =1.2, 95% CI: 1.038-1.387, P=0.014), dominant (AA/ GA vs GG, OR =1.215, 95% CI: 1.058-1.395, P=0.006), and heterozygous models (GA vs GG, OR =1.185, 95% CI:
1.048-1.339, P=0.007), while it was decreased in hospitalbased studies under dominant (AA/GA vs GG, OR =0.751, 95% CI: 0.577-0.987, P=0.033) and heterozygous models (GA vs GG, OR =0.73, 95% CI: 0.589, 0.905, P=0.004; Figure 5B and Table 2 ). Figure 6 ) and heterozygous models (GA vs GG, OR =0.862, 95% CI: 0.755-0.985, P=0.029). However, no significant association between TNF-308G.A polymorphism and the risk of FL was observed when stratified by ethnicity. Further subgroup analysis based on the source of controls indicated that the risk of FL was only increased in hospital-based studies under homozygous model (AA vs GG, OR =2.533, 95% CI: 1.08-5.938, P=0.033; Table 2 ).
Based on the results of three studies, there was no significant association between TNF-308G.A polymorphism and the susceptibility to chronic lymphocytic leukemia (Table 2) .
TnF-308g.a polymorphism and the risk of T-cell lymphomas and nK/T-cell lymphomas
The pooled results of three studies indicated that a significantly increased risk of T-cell lymphomas (TCL) was observed, when GA genotype was compared with GG genotype (OR =16.759, 95% CI: 7.909-35.477, P,0.001; Figure 7 ). There were no significant correlations between TNF-308G.A and the risk of NK/TCL based on the data of two studies.
evaluation of heterogeneity and publication bias
There were some heterogeneities in the outcomes of overall NHL, BCL, DLBCL, and TCL. We performed subgroup analysis and meta-regression to investigate the sources of heterogeneity among studies. As shown earlier, the heterogeneity was decreased in some of the outcomes after the stratification of ethnicity and source of controls (Table 2) . Furthermore, ethnicity (allelic model, P=0.044; recessive model, P=0.029) and publication years (recessive model, P=0.039) were identified as the sources of heterogeneity based on the results of meta-regression. Therefore, the publication year, ethnicity, and source of controls all may contribute to the heterogeneity exhibited in this meta-analysis. Sensitivity analysis was also performed, and the studies of Hosgood et al 23 and Morton et al 28 were identified as outliers in the outcomes of NHL, DLBCL, and BCL. Publication bias was evaluated using Egger's test and funnel plots, and obvious asymmetry was detected only in the recessive and homozygous models of FL.
Prognosis analysis Characteristics of five pooled studies
We collected the data of five studies, 9,20,21,30,31 including 1,192 patients with NHL to analyze the correlation of TNF-308A with the survival outcomes in patients with NHL. Three studies evaluated the independent prognostic role of TNF-308A (the presence of one or more mutant alleles), and another two studies assessed TNF-308/LT-α+252 polymorphic high-producer alleles (at least two variant alleles). The progression-free survival (PFS) was reported as a survival outcome in three studies, overall survival (OS) in three studies, and probability of event-free survival in one study. The characteristics of the five studies are shown in Table 3 .
TnF-308a and survival outcomes
The pooled results of five studies, involving 1,192 patients with NHL, suggested that TNF-308A was significantly related to poor OS and PFS in patients with NHL, where the pooled HR was 1.526 (95% CI: 1.378-1.690, P,0.001; Figure 8A ) and 1.967 (95% CI: 1.438-2.689, P,0.001; Figure 8B ), respectively. Furthermore, the PFS was shorter among patients with BCL with TNF-308A (HR =2.451, 95% CI: 1.536-3.912, P,0.001; Figure 9 ). The presence of TNF-308A was also associated with worse outcomes in patients with DLBCL (OS: HR =1.437, 95% CI: 1.260-1.638, P,0.001; PFS: HR =1.555, 95% CI: 1.325-1.826, P,0.001; Table 4 ).
sensitivity analysis and publication bias
With substantial heterogeneity in the results of PFS in patients with NHL and BCL, the sensitivity analysis was performed to evaluate the influence of single study on the overall estimate, and the study of Osman et al was identified as an outlier. No publication bias was observed except OS in patients with NHL (P=0.044).
Discussion
The research suggested that TNF-308A could be utilized to identify the potential susceptible population of NHL. 36 We extended the previous meta-analyses and reviews to further assess the association of TNF-308A with the risk of NHL in different ethnicities and the source of controls. Our results showed that TNF-308A may be a risk factor of overall NHL, BCL, and DLBCL in Caucasians and healthy population, but not in Asian and hospital population. Besides, the risk of FL was also decreased in the carriers of TNF-308A.
In line with the previous two meta-analyses and reviews, 13, 14 our analysis confirmed the associations of TNF-308G.A with the increased risks of all NHL and BCL in Caucasians and decreased risks in Asians. The different risks of NHL in Caucasians and Asians suggested that ethnic background and genetic structure played a critical role in the susceptibility to NHL. 37 Contrary to Zhai et al's study, 14 this significant association was observed only when GA genotype was compared with GG genotype, rather than the additive model (A vs G) in the recent one, which may be explained by the fact that AA genotype of TNF-308 was unlikely to influence the risk of NHL, as indicated in a pooled analysis. 13 Besides, there was no significant association between TNF-308G.A and the decreased risk of DLBCL in Asians, which was consistently reported in the previous two meta-analyses. 13, 14 It is possible Abbreviations: BCL, B-cell lymphomas; CI, confidence interval; DLBCL, diffuse large B-cell lymphomas; FL, follicular lymphomas; HR, hazard ratio; LT-α, lymphotoxin-α; nhl, non-hodgkin lymphoma; Os, overall survival; peFs, probability of event-free survival; PFs, progression-free survival; TnF, tumor necrosis factor.
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TnF-308 polymorphism and the risk of nhl and prognosis that the substantial heterogeneity among Asian subgroups makes it insignificant in our meta-analysis. Contrary to the previous results of meta-analysis, our results showed that TNF-308G.A reduced the risks of FL among 1,559 cases and 10,669 controls. However, the previous meta-analysis, based on the data of eight studies from the International Lymphoma Epidemiology Consortium, suggested that no significant association was detected between TNF-308G.A and the risk of FL. 12 Similarly, no pronounced association was observed neither in the extended meta-analysis 14 This could largely be attributed to the small number of cases in the previous two studies. Besides, the insignificant association may also be the results of the genetic models used in the recent one in which this association was assessed only in the additive model (A vs G), whereas this correlation was shown in dominant and heterozygous models in the present meta-analysis.
We also performed the subgroup analysis based on the source of controls, which demonstrated a significantly decreased risk of NHL, BCL, and DLBCL in hospital-based studies, whereas increased risk of DLBCL and BCL in population-based studies. The plausible explanation may be that many risk factors of NHL are relatively common in hospital patients, such as smoking, 38 obesity, 39 and immune system disease, 34 compared with healthy population. This contrary conclusion also suggested that the source of controls should be taken into account when the association of TNF-308G.A with the susceptibility to NHL was interpreted. However, the stratified analysis by the source of controls had not been performed in the previous three meta-analyses. [12] [13] [14] According to the results of sensitivity analysis, the studies of Hosgood et al 23 and Morton et al 28 were identified as outliers in the susceptibility analysis of NHL, BCL, and DLBCL. It is noted that the risk of NHL in Asian populations was contrary to Caucasians. However, the study of Hosgood et al focused on three Asian populations, including Hong Kong, South Korea, and People's Republic of China, which enrolled 2,635 NHL cases and 4,234 controls, while other studies of Asian populations were in smaller numbers. As such, the result of this larger Asian population may be one of the resources of heterogeneity among the pooled population. The control group of Morton et al's study consisted of a small percentage of African-Americans, while the population was mainly Caucasians in the study of Morton et al. 28 The research showed that the risk of NHL was higher in African-Americans than in other ethnicities. This mixed ethnicity may also be a source of difference in overall outcomes. In addition to the results of genetic susceptibility to TNF-308G.A, we examined the potential correlation between TNF-308A and the survival outcome in patients with NHL, which had not been examined in the previous meta-analyses. The PFS and OS were shorter in patients with NHL with TNF-308A, based on the data of 1,192 patients with NHL. Besides, the present results indicated that TNF-308A was a risk factor for the survival outcome in patients with BCL and DLBCL. Consistent with the study of Cerhan et al, 32 no significant association of TNF-308A with survival was detected in patients with FL in the study of Warzocha et al. 21 Lymphotoxin-α (LTA) 252A.G was in linkage disequilibrium with TNF-308G.A, which led to the inseparable effect of survival in the studies of Seidemann et al 30 and Warzocha et al. 21 Both of the studies suggested that the highrisk haplotype (the presence of two or more alleles, either TNF-A or LTA-α) was associated with poorer survival outcome (Table 4) . Nevertheless, previous studies indicated that TNF-308 is the primary contributor of worse survival outcome of patients with NHL, and its association with LTA 252 was insignificant. 40 Therefore, we may conclude that the presence of TNF-308A is a predictor of worse prognosis of NHL.
According to the results of sensitivity analysis of survival outcomes, hazard ratio (HR) was much higher than the HR in the other four studies in the study of Osman et al. 9 It is likely that this higher risk leads to the substantial heterogeneity exhibited in the result of PFS in NHL and BCL.
limitations and future directions
We searched only six databases for all available full texts and failed to include all the studies from the International Lymphoma Epidemiology Consortium due to the unavailable access to full text, which had been repeatedly used in the previous meta-analyses. Besides, the less common histological subtypes were reported in few studies, limiting the statistical power of pooled estimated OR and hindering a more thorough interpretation of the associations between TNF-308G.A and NHL subtypes. Moreover, we acknowledged that the population selection bias may exist in our study, with only Asians and Caucasians in the susceptibility analysis and Caucasians in prognosis analysis. Finally, only five studies were included to evaluate the correlation of TNF-308G.A and NHL survival. It is hard to exclude the possibility that this correlation may become insignificant after pooling the results of more studies. 
1669
TnF-308 polymorphism and the risk of nhl and prognosis
Future expanded studies that would investigate the correlation of TNF-308 with other rare NHL subtypes may be warranted. Similarly, future efforts are also needed to assess the role of TNF-308A with the risk of NHL in larger Asian and African populations. Considering the small number of prognosis analyses, future studies that would explore the prognosis value of TNF-308 in patients with NHL may further refine our current outcomes.
Conclusion
Overall, our study found that TNF-308G.A polymorphism was associated not only with increased risks of NHL, BCL, and TCL and decreased risk of FL but also with shorter PFS and OS in patients with NHL, BCL, and DLBCL. However, those associations varied among different ethnicities and the source of controls, in which increased risk of NHL, BCL, and DLBCL was observed in Caucasians, whereas decreased risk of NHL and BCL in Asians. Meanwhile, the risk of NHL, BCL, and DLBCL was decreased in hospital-based population, while the risk of BCL and DLBCL was increased in population-based studies. Future studies focused on other NHL subtypes, and ethnicity groups may further our understanding of the association of TNF-308 with the susceptibility to and prognosis of NHL and its subtypes.
